| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Department of Medicine, University of California School of Medicine, San Francisco, CA 94143-1270, USA
2 Robert H. Lurie Cancer Center, Northwestern University, School of Medicine, Chicago, IL 60611, USA
Most human immunodeficiency virus (HIV)-infected individuals show evidence of infection by only one strain of the virus despite possible frequent contact with multiple strains. The reason(s) for the emergence of a dominant strain of virus in HIV-infected people and the mechanism(s) which prevent other strains from establishing an infection is not known. In the present study, we demonstrate that peripheral blood mononuclear cells (PBMC) of asymptomatic HIV-infected individuals can resist productive infection by HIV-1 and HIV-2 strains. Although the PBMC of these individuals are resistant to superinfection, their CD4+ cells are susceptible to infection. Moreover, two weeks after infection of their PBMC in culture, the superinfecting virus can be recovered from isolated CD4+ cells. When CD8+ cells from asymptomatic individuals are added to the superinfected CD4+ cells, replication of the exogenously introduced virus is inhibited. In contrast, PBMC from individuals who have progressed to disease (Progressors) do not resist superinfection and their CD8+ cells do not show the antiviral activity which controls productive HIV infection. These findings suggest that CD8+ cells suppressing HIV replication in infected individuals may be critical in preventing the establishment of infection by other strains of HIV by blocking virus replication.
Received 22 July 1996;
accepted 30 August 1996.
This article has been cited by other articles:
|
|
 |
|
  A. Lesner, Y. Li, J. Nitkiewicz, G. Li, A. Kartvelishvili, M. Kartvelishvili, and M. Simm A Soluble Factor Secreted by an HIV-1-Resistant Cell Line Blocks Transcription through Inactivating the DNA-Binding Capacity of the NF-{kappa}B p65/p50 Dimer J. Immunol., August 15, 2005; 175(4): 2548 - 2554. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Quinones-Mateu, Y. Gao, S. C. Ball, A. J. Marozsan, A. Abraha, and E. J. Arts In Vitro Intersubtype Recombinants of Human Immunodeficiency Virus Type 1: Comparison to Recent and Circulating In Vivo Recombinant Forms J. Virol., August 28, 2002; 76(19): 9600 - 9613. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Le Borgne, M. Février, C. Callebaut, S. P. Lee, and Y. Rivière CD8+-Cell Antiviral Factor Activity Is Not Restricted to Human Immunodeficiency Virus (HIV)-Specific T Cells and Can Block HIV Replication after Initiation of Reverse Transcription J. Virol., May 15, 2000; 74(10): 4456 - 4464. [Abstract] [Full Text]
|
|
|
|
|
|
L. A. Pinto, V. Blazevic, B. K. Patterson, C. Mac Trubey, M. J. Dolan, and G. M. Shearer Inhibition of Human Immunodeficiency Virus Type 1 Replication prior to Reverse Transcription by Influenza Virus Stimulation J. Virol., May 15, 2000; 74(10): 4505 - 4511. [Abstract] [Full Text]
|
|
|
|
 |
|
 C. E. Mackewicz, B. K. Patterson, S. A. Lee, and J. A. Levy CD8+ cell noncytotoxic anti-human immunodeficiency virus response inhibits expression of viral RNA but not reverse transcription or provirus integration J. Gen. Virol., May 1, 2000; 81(5): 1261 - 1264. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. A. Pinto, V. Blazevic, G. M. Shearer, B. K. Patterson, and M. J. Dolan Alloantigen-induced anti-HIV activity occurs prior to reverse transcription and can be generated by leukocytes from HIV-infected individuals Blood, March 1, 2000; 95(5): 1875 - 1876. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
